KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Receivables - Net (2016 - 2026)

Bio-Rad Laboratories has reported Receivables - Net over the past 18 years, most recently at $426.2 million for Q1 2026.

  • Quarterly Receivables - Net changed 0.35% to $426.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $426.2 million through Mar 2026, changed 0.35% year-over-year, with the annual reading at $460.6 million for FY2025, 1.79% up from the prior year.
  • Receivables - Net was $426.2 million for Q1 2026 at Bio-Rad Laboratories, down from $460.6 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $498.3 million in Q1 2023 and troughed at $424.7 million in Q1 2025.
  • The 5-year median for Receivables - Net is $460.6 million (2025), against an average of $460.5 million.
  • Year-over-year, Receivables - Net grew 16.79% in 2022 and then fell 10.73% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $494.6 million in 2022, then dropped by 1.14% to $489.0 million in 2023, then dropped by 7.46% to $452.5 million in 2024, then rose by 1.79% to $460.6 million in 2025, then decreased by 7.47% to $426.2 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Receivables - Net are $426.2 million (Q1 2026), $460.6 million (Q4 2025), and $464.7 million (Q3 2025).